BSE Fundamental Analysis - Balance Sheet & Share Holding Pattern

ARIHANTMULTICOMMERCIAL01 Jan 1900

₹

0.00 (0.00%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in

ARIHANTMULTICOMMERCIAL01 Jan 1900

₹

0.00 (0.00%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date	Ratio
30-Sep-2013	S	Lifeline Drugs & Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 01, 2013 have considered the following resolutions subject to the approval of Shareholders in Extra-Ordinary General Meeting - 1. Split/Sub-division of Equity Shares of the Company of the face value of Rs. 10/- (Rs. Ten) each to the face value of Rs. 1/- (Rs. One) each. Lifeline Drugs & Pharma Ltd has informed BSE that members of the Company have approved following resolutions in the Extra Ordinary General Meeting (EGM) held on October 28, 2013 : - Approved the sub-division in face value of Equity Shares of Rs. 10/- (Rs. Ten) to Rs. 1/- (Rs. One). (As per BSE Announcement Dated on 28.10.2013) SUB. :- Sub Division of equity shares of Lifeline Drugs & Pharma Limited (Scrip Code 506113) Trading Members of the Exchange are hereby informed that, Lifeline Drugs & Pharma Limited has fixed the Record Date for the purpose of sub division of equity shares of the company. DEMATERIALISED SECURITIES û ROLLING SETTLEMENT SEGMENT COMPANY NAME & CODE Lifeline Drugs & Pharma Limited (506113) RECORD DATE 15.11.2013 PURPOSE Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each. SUB-DIVIDED PAID-UP VALUE Re.1/- SUB-DIVIDED PAID-UP VALUE W.E.F. 13/11/2013 DR-158/2013- 2014 Note :- i. Trading members are hereby informed that the transactions in the equity shares (physical) of the aforesaid company in the Exit-Route Scheme will be for Re. 1/- paid up w.e.f. 13/11/2013. ii. ISIN No. INE776N01010 of Rs.10/- paid up will not be valid for transactions done on the Exchange on or after 13/11/2013. iii. The new ISIN Number for Re.1/- paid up will be informed to the market by a separate notice. (As Per BSE Notice Dated on 29.10.2013) Sub: Revised Record Dates for Securities This is in furtherance to the notice no. 20131113-25 dated Wednesday, November 13, 2013 issued by Indian Clearing Corporation Ltd regarding revised settlement schedule. Trading Members of the Exchange are hereby requested to note the revised Record Dates, as informed by the respective companies, for the corporate actions of following securities: - Company Name & Scrip Code Lifeline Drugs & Pharma Limited (506113) Revised Record Date 18.11.2013 Purpose Sub Division of existing equity shares from every ONE equity share of Rs.10/- each into TEN equity shares of Re.1/- each. Ex- Date 13/11/2013 Ex-Settlement. No DR-158/2013-14 Trading Members are requested to take note of the same. (As Per BSE Notice Dated on 14.11.2013)	18-Nov-2013
06-Jun-2014	D	Lifeline Drugs & Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 06, 2014, have approved payments of Interim Dividend @ 0.10 paise on Equity Share of Rs. 1/- each for financial year 2014-15.	19-Jun-2014
20-Sep-2010	D	Lifeline Drugs & Pharma Ltd has now informed BSE that the Board of Directors of the Company at its meeting held on May 29, 2010, inter alia, have recommended Dividend @ 10% i.e. Re. 1/- per share. However, declaration of dividend will be subject to approval of shareholders at the ensuing Annual General Meeting.	21-Sep-2010
30-Jun-2009	D	Lifeline Drugs & Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2009, inter alia, has recommended Dividend @ 10% i.e. Rs 1/- per share. However, declaration of dividend will be subject to approval of shareholders at the ensuing Annual General Meeting.	11-Sep-2009
30-Jun-2008	D	Lifeline Drugs & Pharma Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 30, 2008, inter alia, has recommended final Dividend of 10% for the FY 2007-08 subject to approval of Members in the ensuing Annual General Meeting.	11-Sep-2008
09-Jul-2012	B	4:1 Bonus Issue of Equity Shares SUB. :- Bonus issue of Lifeline Drugs and Pharma Ltd. (Scrip Code: 506113) Trading Members of the Exchange are hereby informed that Lifeline Drugs and Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date. PHYSICAL SECURITIES-PHYSICAL IN COMPULSORY ROLLING COMPANY NAME & CODE Lifeline Drugs and Pharma Ltd. (506113) RECORD DATE 24.07.2012 PURPOSE Issue of 4 (FOUR) fully paid up Bonus equity shares of Rs. 10/- each for every 1 (ONE) fully paid up equity share of Rs. 10/- each held. Ex-Bonus basis from Date & Sett. No. 12/07/2012 DR-074/2012-2013 Note: The scrip will be in No Delivery from 12/07/2012 (DR-074/2012-2013) to 27/07/2012 (DR-085/2012-2013). Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 09.07.2012) SUB. :- Bonus issue of Lifeline Drugs and Pharma Ltd. (Scrip Code. 506113) This is in continuation of Notice No. 20120709-20 dated July 09, 2012 informing therein about Bonus issue of Lifeline Drugs and Pharma Ltd. (Scrip code: 506113). Lifeline Drugs & Pharma Ltd has informed BSE that in view of the on going Open Offer, the Company has decided to cancel the record date i.e. July 24, 2012 for the purpose of issue of Bonus Shares in compliance with Regulation 26(4) of SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. The new record date will be intimated at a later date. Trading Members are requested to take note of the above. (As Per BSE Notice Dated on 11.07.2012) SUB. :- Bonus issue of Lifeline Drugs and Pharma Ltd. (Scrip Code: 506113) This is in continuation of Notice No. 20120709-20 dated July 09, 2012 and Notice No. 20120711-17 dated July 11, 2012 informing therein about Bonus issue of Lifeline Drugs and Pharma Ltd. (Scrip code: 506113). Trading Members of the Exchange are hereby informed that Lifeline Drugs and Pharma Ltd. has fixed the Record Date for the purpose of Bonus Issue. The transactions in the equity shares of the Company should be on an ex-bonus basis with effect from the under mentioned date. PHYSICAL SECURITIES - PHYSICAL IN COMPULSORY ROLLING COMPANY NAME & CODE Lifeline Drugs and Pharma Ltd. (506113) RECORD DATE 16/08/2012 PURPOSE Issue of 4 (FOUR) fully paid up Bonus equity shares of Rs. 10/- each for every 1 (ONE) fully paid up equity share of Rs. 10/- each held. Ex-Bonus basis from Date & Sett. No. 07/08/2012 DR-092/2012-2013 Note: The scrip will be in No Delivery from 07/08/2012 (DR-092/2012-2013) to 21/08/2012 (DR-100/2012-2013). Trading Members of the Exchange are requested to take note of it. (As Per BSE Notice Dated on 06.08.2012)	16-Aug-2012	4:1
21-Nov-2023	BC	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with	23-Nov-2023
18-Jan-2020	BC	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th	12-Dec-2019
18-Jan-2020	BC	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th	12-Dec-2019
18-Jan-2020	BC	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th	29-May-2019
18-Jan-2020	BC	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th	29-May-2019

No Rights has been declared by ARIHANTMULTICOMMERCIAL

Book Closure

Record Date	Split Date	Purpose
23-Nov-2023	-	Trading Members of the Exchange are hereby informed that the undermentioned 73 companies that have remained suspended for more than 6 months would be delisted from the platform of the Exchange, with
12-Dec-2019	-	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th
12-Dec-2019	-	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th
29-May-2019	-	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th
29-May-2019	-	In reference to the captioned subject and in accordance with Regulation 30 of SEBI (Listing Obligation and Disclosure Requirement) Regulation, 2015, you are hereby informed that, in the meeting of th

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Sreeleathers Ltd ₹309.50(-0.55/-0.18%)	309.50	-0.55	717.92	66.96	24.90	1.81
Integra Essentia Ltd ₹4.45(+0.20/4.71%)	4.45	+0.20	388.48	22.13	25.59	3.40
Kothari Products Ltd ₹133.60(-0.50/-0.37%)	133.60	-0.50	400.21	16.41	79.70	0.42
Hexa Tradex Ltd ₹151.20(+0.15/0.10%)	151.20	+0.15	834.55	2.34	0.00	0.33
Future Consumer Ltd ₹0.95(+0.05/5.56%)	0.95	+0.05	179.73	-25.00	0.00	-0.77

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Dec 17	Sep 17	Jun 17	Mar 17	Dec 16
Gross Sales	3.40	0.20	0.19	0.36	2.98	0.00
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	3.40	0.20	0.19	0.36	2.98	0.00
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	0.33	0.22	0.22	0.23	0.28	0.27
Total Income	3.74	0.42	0.41	0.59	3.26	0.27
Total Expenditure	4.23	0.26	0.28	0.37	4.02	0.00
PBIDT	-0.49	0.15	0.12	0.22	-0.76	0.27
Interest	0.00	0.00	0.00	0.00	0.00	0.00
PBDT	-0.49	0.15	0.12	0.22	-0.76	0.27
Depreciation	0.00	0.00	0.00	0.00	0.00	0.00
Tax	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Reported Profit After Tax	-0.50	0.15	0.12	0.22	-0.76	0.27
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	-0.50	0.15	0.12	0.22	-0.76	0.27

EPS (Unit Curr.)	-0.14	0.04	0.03	0.06	-0.21	0.08
EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Unit Curr.)	-0.14	0.04	0.03	0.06	-0.21	0.08
Calculated EPS (Adj) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Calculated EPS (Ann.) (Unit Curr.)	-0.55	0.17	0.13	0.24	-0.84	0.30
Calculated EPS (Adj) (Ann.) (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	3.62	3.62	3.62	3.62	3.62	3.62
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	1.00	1.00	1.00	1.00	1.00	1.00

Public Shareholding (No. Of Shares)	36215000.00	36215000.00	36215000.00	36215000.00	36215000.00	36215000.00
Public Shareholding (% in Equity)	99.93	99.93	99.93	99.93	99.93	99.93

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	25000.00	25000.00	25000.00	25000.00	25000.00	25000.00
Non Encumbered - % in Total Promoters Holding	100.00	100.00	100.00	100.00	100.00	100.00
Non Encumbered - % in Total Equity	0.07	0.07	0.07	0.07	0.07	0.07

PBIDTM(%)	-14.41	75.00	63.16	61.11	-25.50	0.00
PBDTM(%)	-14.41	75.00	63.16	61.11	-25.50	0.00
PATM(%)	-14.71	75.00	63.16	61.11	-25.50	0.00

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 18	Mar 17	Mar 16	Mar 15	Mar 14	Mar 13
SOURCES OF FUNDS :
Share Capital	3.62	3.62	3.62	3.62	3.62	3.07
Reserves Total	17.97	17.97	17.97	17.91	17.65	9.68
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	0.00	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	21.59	21.59	21.59	21.53	21.27	12.75
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Total Debt	0.00	0.00	0.00	0.00	0.00	0.00
Total Liabilities	21.59	21.59	21.59	21.53	21.27	12.75
APPLICATION OF FUNDS :
Gross Block	0.02	0.02	0.02	0.02	0.01	0.00
Less : Accumulated Depreciation	0.02	0.02	0.02	0.01	0.00	0.00
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	0.00	0.00	0.00	0.01	0.01	0.00
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.00	0.00	0.00	0.00	0.00	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	0.00	0.00	0.00	0.00	0.00	0.00
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	9.14	3.06	1.23	0.73	0.08	8.40
Sundry Debtors	0.05	2.25	43.51	11.92	9.72	1.70
Cash and Bank	0.27	0.03	0.04	2.16	0.23	0.11
Loans and Advances	13.54	18.84	19.36	17.17	22.77	2.77
Total Current Assets	23.01	24.18	64.14	31.98	32.78	12.97
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	1.51	2.56	42.42	10.22	11.13	0.00
Provisions	0.00	0.03	0.14	0.23	0.39	0.22
Total Current Liabilities	1.51	2.59	42.56	10.45	11.52	0.22
Net Current Assets	21.50	21.59	21.58	21.53	21.27	12.76
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Liability	0.00	0.00	0.00	0.00	0.00	0.00
Net Deferred Tax	0.00	0.00	0.00	0.00	0.00	0.00
Total Assets	21.50	21.59	21.59	21.54	21.28	12.76
Contingent Liabilities	0.00	0.00	0.00	0.00	0.00	0.00

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2018	Mar 2017	Mar 2016	Mar 2015	Mar 2014
Cash and Cash Equivalents at Beginning of the year	0.03	0.04	2.16	0.22	0.10
Net Cash from Operating Activities	-0.66	-1.10	-3.33	0.65	-8.51
Net Cash Used In Investing Activities	0.90	1.09	1.21	1.64	0.76
Net Cash Used In Financing Activities	0.00	0.00	0.00	-0.36	7.87
Net Inc./Dec In Cash And Cash Equivalents	0.24	-0.01	-2.12	1.93	0.12
Cash And Cash Equivalents At End Of The Year	0.27	0.03	0.04	2.15	0.22

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

0.07%

FII Shareholding

0.00%

DII Shareholding

0.00%

Public Shareholding

99.93%

**Promoter pledged shareholding 0.07%

About Arihant Multi Commercial Ltd

Arihant Multi Commercial Ltd is in the Trading sector, having a market capitalization of Rs. 487.07 crores. It has reported a sales of Rs. 3.4 crores and a net profit of Rs. -0.5 crores for the quarter ended December 2018. The company management includes , Ranjit Modi,Deepak S Bansal,Mahesh H Parihar,Bhakti B Soni,Jaydeep Matieda,Pavan Kr. Singh,Karishma Kaku (Arihant Multi Commercial Ltd) among others.

Chairman

Registered office

F/3 Shah Arcade 1,Dhanjiwadi Malad (E),Mumbai,Maharashtra,400097

FAX :91-22-28822183

Background

Incorporation Year1982

Face Value₹1

Market Lot1

How to buy shares on nse?

To buy shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the share price today?

The shares price on nse is Rs.0 today.

What is the market cap of shares on ?

The company has a market capitalization of Rs.0.00Cr

What is the PE & PB ratio of shares ?

PE is 0 and PB is 0

What is the 52 Week High and Low of shares?

stock price high: Rs.0 stock price low: Rs.0